Global Cell Therapy CDMO Market Growth (Status and Outlook) 2025-2031
The global Cell Therapy CDMO market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cell Therapy CDMO players cover Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Cell Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell Therapy CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO sales for 2025 through 2031. With Cell Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cell Therapy CDMO players cover Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Cell Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cell Therapy CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO sales for 2025 through 2031. With Cell Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Stem Cell
- Non-Stem Cell
- Commercial
- Academic Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Charles River
- The Discovery Labs
- BIOCENTRIQ
- FUJIFILM Diosynth Biotechnologies
- Exothera
- WuXi AppTec
- Pharmaron
- OBiO
- Cell Therapies
- AGC Biologics
- Cytiva
- Helixmith
- ThermoGenesis
- Anemocyte
- Thermo Fisher Scientific
- CBM
- Bio Elpida
- Genezen
- CCRM
- RoslinCT
- GenScript ProBio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CDMO Market Size (2020-2031)
2.1.2 Cell Therapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cell Therapy CDMO by Country/Region (2020, 2024 & 2031)
2.2 Cell Therapy CDMO Segment by Type
2.2.1 Stem Cell
2.2.2 Non-Stem Cell
2.3 Cell Therapy CDMO Market Size by Type
2.3.1 Cell Therapy CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cell Therapy CDMO Market Size Market Share by Type (2020-2025)
2.4 Cell Therapy CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Others
2.5 Cell Therapy CDMO Market Size by Application
2.5.1 Cell Therapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cell Therapy CDMO Market Size Market Share by Application (2020-2025)
3 CELL THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell Therapy CDMO Revenue by Player (2020-2025)
3.1.2 Global Cell Therapy CDMO Revenue Market Share by Player (2020-2025)
3.2 Global Cell Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO BY REGION
4.1 Cell Therapy CDMO Market Size by Region (2020-2025)
4.2 Global Cell Therapy CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cell Therapy CDMO Market Size Growth (2020-2025)
4.4 APAC Cell Therapy CDMO Market Size Growth (2020-2025)
4.5 Europe Cell Therapy CDMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Cell Therapy CDMO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Cell Therapy CDMO Market Size by Country (2020-2025)
5.2 Americas Cell Therapy CDMO Market Size by Type (2020-2025)
5.3 Americas Cell Therapy CDMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CDMO Market Size by Region (2020-2025)
6.2 APAC Cell Therapy CDMO Market Size by Type (2020-2025)
6.3 APAC Cell Therapy CDMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CDMO Market Size by Country (2020-2025)
7.2 Europe Cell Therapy CDMO Market Size by Type (2020-2025)
7.3 Europe Cell Therapy CDMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CDMO by Region (2020-2025)
8.2 Middle East & Africa Cell Therapy CDMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Cell Therapy CDMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CDMO MARKET FORECAST
10.1 Global Cell Therapy CDMO Forecast by Region (2026-2031)
10.1.1 Global Cell Therapy CDMO Forecast by Region (2026-2031)
10.1.2 Americas Cell Therapy CDMO Forecast
10.1.3 APAC Cell Therapy CDMO Forecast
10.1.4 Europe Cell Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell Therapy CDMO Forecast
10.2 Americas Cell Therapy CDMO Forecast by Country (2026-2031)
10.2.1 United States Market Cell Therapy CDMO Forecast
10.2.2 Canada Market Cell Therapy CDMO Forecast
10.2.3 Mexico Market Cell Therapy CDMO Forecast
10.2.4 Brazil Market Cell Therapy CDMO Forecast
10.3 APAC Cell Therapy CDMO Forecast by Region (2026-2031)
10.3.1 China Cell Therapy CDMO Market Forecast
10.3.2 Japan Market Cell Therapy CDMO Forecast
10.3.3 Korea Market Cell Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell Therapy CDMO Forecast
10.3.5 India Market Cell Therapy CDMO Forecast
10.3.6 Australia Market Cell Therapy CDMO Forecast
10.4 Europe Cell Therapy CDMO Forecast by Country (2026-2031)
10.4.1 Germany Market Cell Therapy CDMO Forecast
10.4.2 France Market Cell Therapy CDMO Forecast
10.4.3 UK Market Cell Therapy CDMO Forecast
10.4.4 Italy Market Cell Therapy CDMO Forecast
10.4.5 Russia Market Cell Therapy CDMO Forecast
10.5 Middle East & Africa Cell Therapy CDMO Forecast by Region (2026-2031)
10.5.1 Egypt Market Cell Therapy CDMO Forecast
10.5.2 South Africa Market Cell Therapy CDMO Forecast
10.5.3 Israel Market Cell Therapy CDMO Forecast
10.5.4 Turkey Market Cell Therapy CDMO Forecast
10.6 Global Cell Therapy CDMO Forecast by Type (2026-2031)
10.7 Global Cell Therapy CDMO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cell Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River Cell Therapy CDMO Product Offered
11.1.3 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Information
11.2.2 The Discovery Labs Cell Therapy CDMO Product Offered
11.2.3 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 The Discovery Labs Main Business Overview
11.2.5 The Discovery Labs Latest Developments
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Information
11.3.2 BIOCENTRIQ Cell Therapy CDMO Product Offered
11.3.3 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BIOCENTRIQ Main Business Overview
11.3.5 BIOCENTRIQ Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Exothera
11.5.1 Exothera Company Information
11.5.2 Exothera Cell Therapy CDMO Product Offered
11.5.3 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Exothera Main Business Overview
11.5.5 Exothera Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Cell Therapy CDMO Product Offered
11.6.3 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Information
11.7.2 Pharmaron Cell Therapy CDMO Product Offered
11.7.3 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pharmaron Main Business Overview
11.7.5 Pharmaron Latest Developments
11.8 OBiO
11.8.1 OBiO Company Information
11.8.2 OBiO Cell Therapy CDMO Product Offered
11.8.3 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 OBiO Main Business Overview
11.8.5 OBiO Latest Developments
11.9 Cell Therapies
11.9.1 Cell Therapies Company Information
11.9.2 Cell Therapies Cell Therapy CDMO Product Offered
11.9.3 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cell Therapies Main Business Overview
11.9.5 Cell Therapies Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell Therapy CDMO Product Offered
11.10.3 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Cytiva
11.11.1 Cytiva Company Information
11.11.2 Cytiva Cell Therapy CDMO Product Offered
11.11.3 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cytiva Main Business Overview
11.11.5 Cytiva Latest Developments
11.12 Helixmith
11.12.1 Helixmith Company Information
11.12.2 Helixmith Cell Therapy CDMO Product Offered
11.12.3 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Helixmith Main Business Overview
11.12.5 Helixmith Latest Developments
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Information
11.13.2 ThermoGenesis Cell Therapy CDMO Product Offered
11.13.3 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ThermoGenesis Main Business Overview
11.13.5 ThermoGenesis Latest Developments
11.14 Anemocyte
11.14.1 Anemocyte Company Information
11.14.2 Anemocyte Cell Therapy CDMO Product Offered
11.14.3 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Anemocyte Main Business Overview
11.14.5 Anemocyte Latest Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Information
11.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Offered
11.15.3 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Thermo Fisher Scientific Main Business Overview
11.15.5 Thermo Fisher Scientific Latest Developments
11.16 CBM
11.16.1 CBM Company Information
11.16.2 CBM Cell Therapy CDMO Product Offered
11.16.3 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 CBM Main Business Overview
11.16.5 CBM Latest Developments
11.17 Bio Elpida
11.17.1 Bio Elpida Company Information
11.17.2 Bio Elpida Cell Therapy CDMO Product Offered
11.17.3 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Bio Elpida Main Business Overview
11.17.5 Bio Elpida Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Cell Therapy CDMO Product Offered
11.18.3 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 CCRM
11.19.1 CCRM Company Information
11.19.2 CCRM Cell Therapy CDMO Product Offered
11.19.3 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 CCRM Main Business Overview
11.19.5 CCRM Latest Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Information
11.20.2 RoslinCT Cell Therapy CDMO Product Offered
11.20.3 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 RoslinCT Main Business Overview
11.20.5 RoslinCT Latest Developments
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Information
11.21.2 GenScript ProBio Cell Therapy CDMO Product Offered
11.21.3 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 GenScript ProBio Main Business Overview
11.21.5 GenScript ProBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CellTherapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CellTherapy CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Stem Cell
Table 4. Major Players of Non-Stem Cell
Table 5. CellTherapy CDMO Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 7. Global CellTherapy CDMO Market Size Market Share byType (2020-2025)
Table 8. CellTherapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Table 11. Global CellTherapy CDMO Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CellTherapy CDMO Revenue Market Share by Player (2020-2025)
Table 13. CellTherapy CDMO Key Players Head office and Products Offered
Table 14. CellTherapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Table 19. Global CellTherapy CDMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CellTherapy CDMO Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CellTherapy CDMO Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CellTherapy CDMO Market Size Market Share by Country (2020-2025)
Table 23. Americas CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 24. Americas CellTherapy CDMO Market Size Market Share byType (2020-2025)
Table 25. Americas CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Table 27. APAC CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Table 29. APAC CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 30. APAC CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CellTherapy CDMO Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CellTherapy CDMO Market Size Market Share by Country (2020-2025)
Table 33. Europe CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 34. Europe CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CellTherapy CDMO
Table 39. Key Market Challenges & Risks of CellTherapy CDMO
Table 40. Key IndustryTrends of CellTherapy CDMO
Table 41. Global CellTherapy CDMO Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global CellTherapy CDMO Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global CellTherapy CDMO Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global CellTherapy CDMO Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Charles River Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 46. Charles River CellTherapy CDMO Product Offered
Table 47. Charles River CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Charles River Main Business
Table 49. Charles River Latest Developments
Table 50.The Discovery Labs Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 51.The Discovery Labs CellTherapy CDMO Product Offered
Table 52.The Discovery Labs CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.The Discovery Labs Main Business
Table 54.The Discovery Labs Latest Developments
Table 55. BIOCENTRIQ Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 56. BIOCENTRIQ CellTherapy CDMO Product Offered
Table 57. BIOCENTRIQ CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. BIOCENTRIQ Main Business
Table 59. BIOCENTRIQ Latest Developments
Table 60.FUJIFILM Diosynth Biotechnologies Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 61.FUJIFILM Diosynth Biotechnologies CellTherapy CDMO Product Offered
Table 62.FUJIFILM Diosynth Biotechnologies CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.FUJIFILM Diosynth Biotechnologies Main Business
Table 64.FUJIFILM Diosynth Biotechnologies Latest Developments
Table 65. Exothera Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 66. Exothera CellTherapy CDMO Product Offered
Table 67. Exothera CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Exothera Main Business
Table 69. Exothera Latest Developments
Table 70. WuXi AppTec Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 71. WuXi AppTec CellTherapy CDMO Product Offered
Table 72. WuXi AppTec CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. WuXi AppTec Main Business
Table 74. WuXi AppTec Latest Developments
Table 75. Pharmaron Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 76. Pharmaron CellTherapy CDMO Product Offered
Table 77. Pharmaron CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pharmaron Main Business
Table 79. Pharmaron Latest Developments
Table 80. OBiO Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 81. OBiO CellTherapy CDMO Product Offered
Table 82. OBiO CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. OBiO Main Business
Table 84. OBiO Latest Developments
Table 85. CellTherapies Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 86. CellTherapies CellTherapy CDMO Product Offered
Table 87. CellTherapies CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. CellTherapies Main Business
Table 89. CellTherapies Latest Developments
Table 90. AGC Biologics Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 91. AGC Biologics CellTherapy CDMO Product Offered
Table 92. AGC Biologics CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AGC Biologics Main Business
Table 94. AGC Biologics Latest Developments
Table 95. Cytiva Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 96. Cytiva CellTherapy CDMO Product Offered
Table 97. Cytiva CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cytiva Main Business
Table 99. Cytiva Latest Developments
Table 100. Helixmith Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 101. Helixmith CellTherapy CDMO Product Offered
Table 102. Helixmith CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Helixmith Main Business
Table 104. Helixmith Latest Developments
Table 105.ThermoGenesis Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 106.ThermoGenesis CellTherapy CDMO Product Offered
Table 107.ThermoGenesis CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108.ThermoGenesis Main Business
Table 109.ThermoGenesis Latest Developments
Table 110. Anemocyte Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 111. Anemocyte CellTherapy CDMO Product Offered
Table 112. Anemocyte CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Anemocyte Main Business
Table 114. Anemocyte Latest Developments
Table 115.ThermoFisher Scientific Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 116.ThermoFisher Scientific CellTherapy CDMO Product Offered
Table 117.ThermoFisher Scientific CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. CBM Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 121. CBM CellTherapy CDMO Product Offered
Table 122. CBM CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. CBM Main Business
Table 124. CBM Latest Developments
Table 125. Bio Elpida Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 126. Bio Elpida CellTherapy CDMO Product Offered
Table 127. Bio Elpida CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Bio Elpida Main Business
Table 129. Bio Elpida Latest Developments
Table 130. Genezen Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 131. Genezen CellTherapy CDMO Product Offered
Table 132. Genezen CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Genezen Main Business
Table 134. Genezen Latest Developments
Table 135. CCRM Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 136. CCRM CellTherapy CDMO Product Offered
Table 137. CCRM CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. CCRM Main Business
Table 139. CCRM Latest Developments
Table 140. RoslinCT Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 141. RoslinCT CellTherapy CDMO Product Offered
Table 142. RoslinCT CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. RoslinCT Main Business
Table 144. RoslinCT Latest Developments
Table 145. GenScript ProBio Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 146. GenScript ProBio CellTherapy CDMO Product Offered
Table 147. GenScript ProBio CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. GenScript ProBio Main Business
Table 149. GenScript ProBio Latest Developments
LIST OFFIGURES
Figure 1. CellTherapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CellTherapy CDMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CellTherapy CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CellTherapy CDMO Sales Market Share by Country/Region (2024)
Figure 8. CellTherapy CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CellTherapy CDMO Market Size Market Share byType in 2024
Figure 10. CellTherapy CDMO in Commercial
Figure 11. Global CellTherapy CDMO Market: Commercial (2020-2025) & ($ millions)
Figure 12. CellTherapy CDMO in Academic Research
Figure 13. Global CellTherapy CDMO Market: Academic Research (2020-2025) & ($ millions)
Figure 14. CellTherapy CDMO in Others
Figure 15. Global CellTherapy CDMO Market: Others (2020-2025) & ($ millions)
Figure 16. Global CellTherapy CDMO Market Size Market Share by Application in 2024
Figure 17. Global CellTherapy CDMO Revenue Market Share by Player in 2024
Figure 18. Global CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 20. APAC CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 21. Europe CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 23. Americas CellTherapy CDMO Value Market Share by Country in 2024
Figure 24. United States CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC CellTherapy CDMO Market Size Market Share by Region in 2024
Figure 29. APAC CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 30. APAC CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 31. China CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe CellTherapy CDMO Market Size Market Share by Country in 2024
Figure 38. Europe CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 39. Europe CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 41.France CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 54. APAC CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 55. Europe CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 57. United States CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 58. Canada CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 61. China CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 62. Japan CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 63. Korea CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 65. India CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 66. Australia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 67. Germany CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 68.France CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 69. UK CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 70. Italy CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 71. Russia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 74. Israel CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 75.Turkey CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 76. Global CellTherapy CDMO Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global CellTherapy CDMO Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries CellTherapy CDMO Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CDMO Market Size (2020-2031)
2.1.2 Cell Therapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cell Therapy CDMO by Country/Region (2020, 2024 & 2031)
2.2 Cell Therapy CDMO Segment by Type
2.2.1 Stem Cell
2.2.2 Non-Stem Cell
2.3 Cell Therapy CDMO Market Size by Type
2.3.1 Cell Therapy CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cell Therapy CDMO Market Size Market Share by Type (2020-2025)
2.4 Cell Therapy CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Others
2.5 Cell Therapy CDMO Market Size by Application
2.5.1 Cell Therapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cell Therapy CDMO Market Size Market Share by Application (2020-2025)
3 CELL THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cell Therapy CDMO Revenue by Player (2020-2025)
3.1.2 Global Cell Therapy CDMO Revenue Market Share by Player (2020-2025)
3.2 Global Cell Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO BY REGION
4.1 Cell Therapy CDMO Market Size by Region (2020-2025)
4.2 Global Cell Therapy CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cell Therapy CDMO Market Size Growth (2020-2025)
4.4 APAC Cell Therapy CDMO Market Size Growth (2020-2025)
4.5 Europe Cell Therapy CDMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Cell Therapy CDMO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Cell Therapy CDMO Market Size by Country (2020-2025)
5.2 Americas Cell Therapy CDMO Market Size by Type (2020-2025)
5.3 Americas Cell Therapy CDMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CDMO Market Size by Region (2020-2025)
6.2 APAC Cell Therapy CDMO Market Size by Type (2020-2025)
6.3 APAC Cell Therapy CDMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CDMO Market Size by Country (2020-2025)
7.2 Europe Cell Therapy CDMO Market Size by Type (2020-2025)
7.3 Europe Cell Therapy CDMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CDMO by Region (2020-2025)
8.2 Middle East & Africa Cell Therapy CDMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Cell Therapy CDMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CDMO MARKET FORECAST
10.1 Global Cell Therapy CDMO Forecast by Region (2026-2031)
10.1.1 Global Cell Therapy CDMO Forecast by Region (2026-2031)
10.1.2 Americas Cell Therapy CDMO Forecast
10.1.3 APAC Cell Therapy CDMO Forecast
10.1.4 Europe Cell Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell Therapy CDMO Forecast
10.2 Americas Cell Therapy CDMO Forecast by Country (2026-2031)
10.2.1 United States Market Cell Therapy CDMO Forecast
10.2.2 Canada Market Cell Therapy CDMO Forecast
10.2.3 Mexico Market Cell Therapy CDMO Forecast
10.2.4 Brazil Market Cell Therapy CDMO Forecast
10.3 APAC Cell Therapy CDMO Forecast by Region (2026-2031)
10.3.1 China Cell Therapy CDMO Market Forecast
10.3.2 Japan Market Cell Therapy CDMO Forecast
10.3.3 Korea Market Cell Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cell Therapy CDMO Forecast
10.3.5 India Market Cell Therapy CDMO Forecast
10.3.6 Australia Market Cell Therapy CDMO Forecast
10.4 Europe Cell Therapy CDMO Forecast by Country (2026-2031)
10.4.1 Germany Market Cell Therapy CDMO Forecast
10.4.2 France Market Cell Therapy CDMO Forecast
10.4.3 UK Market Cell Therapy CDMO Forecast
10.4.4 Italy Market Cell Therapy CDMO Forecast
10.4.5 Russia Market Cell Therapy CDMO Forecast
10.5 Middle East & Africa Cell Therapy CDMO Forecast by Region (2026-2031)
10.5.1 Egypt Market Cell Therapy CDMO Forecast
10.5.2 South Africa Market Cell Therapy CDMO Forecast
10.5.3 Israel Market Cell Therapy CDMO Forecast
10.5.4 Turkey Market Cell Therapy CDMO Forecast
10.6 Global Cell Therapy CDMO Forecast by Type (2026-2031)
10.7 Global Cell Therapy CDMO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cell Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River Cell Therapy CDMO Product Offered
11.1.3 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Information
11.2.2 The Discovery Labs Cell Therapy CDMO Product Offered
11.2.3 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 The Discovery Labs Main Business Overview
11.2.5 The Discovery Labs Latest Developments
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Information
11.3.2 BIOCENTRIQ Cell Therapy CDMO Product Offered
11.3.3 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BIOCENTRIQ Main Business Overview
11.3.5 BIOCENTRIQ Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Exothera
11.5.1 Exothera Company Information
11.5.2 Exothera Cell Therapy CDMO Product Offered
11.5.3 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Exothera Main Business Overview
11.5.5 Exothera Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Cell Therapy CDMO Product Offered
11.6.3 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Information
11.7.2 Pharmaron Cell Therapy CDMO Product Offered
11.7.3 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pharmaron Main Business Overview
11.7.5 Pharmaron Latest Developments
11.8 OBiO
11.8.1 OBiO Company Information
11.8.2 OBiO Cell Therapy CDMO Product Offered
11.8.3 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 OBiO Main Business Overview
11.8.5 OBiO Latest Developments
11.9 Cell Therapies
11.9.1 Cell Therapies Company Information
11.9.2 Cell Therapies Cell Therapy CDMO Product Offered
11.9.3 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cell Therapies Main Business Overview
11.9.5 Cell Therapies Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell Therapy CDMO Product Offered
11.10.3 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Cytiva
11.11.1 Cytiva Company Information
11.11.2 Cytiva Cell Therapy CDMO Product Offered
11.11.3 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cytiva Main Business Overview
11.11.5 Cytiva Latest Developments
11.12 Helixmith
11.12.1 Helixmith Company Information
11.12.2 Helixmith Cell Therapy CDMO Product Offered
11.12.3 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Helixmith Main Business Overview
11.12.5 Helixmith Latest Developments
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Information
11.13.2 ThermoGenesis Cell Therapy CDMO Product Offered
11.13.3 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ThermoGenesis Main Business Overview
11.13.5 ThermoGenesis Latest Developments
11.14 Anemocyte
11.14.1 Anemocyte Company Information
11.14.2 Anemocyte Cell Therapy CDMO Product Offered
11.14.3 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Anemocyte Main Business Overview
11.14.5 Anemocyte Latest Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Information
11.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Offered
11.15.3 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Thermo Fisher Scientific Main Business Overview
11.15.5 Thermo Fisher Scientific Latest Developments
11.16 CBM
11.16.1 CBM Company Information
11.16.2 CBM Cell Therapy CDMO Product Offered
11.16.3 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 CBM Main Business Overview
11.16.5 CBM Latest Developments
11.17 Bio Elpida
11.17.1 Bio Elpida Company Information
11.17.2 Bio Elpida Cell Therapy CDMO Product Offered
11.17.3 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Bio Elpida Main Business Overview
11.17.5 Bio Elpida Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Cell Therapy CDMO Product Offered
11.18.3 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 CCRM
11.19.1 CCRM Company Information
11.19.2 CCRM Cell Therapy CDMO Product Offered
11.19.3 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 CCRM Main Business Overview
11.19.5 CCRM Latest Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Information
11.20.2 RoslinCT Cell Therapy CDMO Product Offered
11.20.3 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 RoslinCT Main Business Overview
11.20.5 RoslinCT Latest Developments
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Information
11.21.2 GenScript ProBio Cell Therapy CDMO Product Offered
11.21.3 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 GenScript ProBio Main Business Overview
11.21.5 GenScript ProBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CellTherapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CellTherapy CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Stem Cell
Table 4. Major Players of Non-Stem Cell
Table 5. CellTherapy CDMO Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 7. Global CellTherapy CDMO Market Size Market Share byType (2020-2025)
Table 8. CellTherapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Table 11. Global CellTherapy CDMO Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CellTherapy CDMO Revenue Market Share by Player (2020-2025)
Table 13. CellTherapy CDMO Key Players Head office and Products Offered
Table 14. CellTherapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Table 19. Global CellTherapy CDMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CellTherapy CDMO Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CellTherapy CDMO Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CellTherapy CDMO Market Size Market Share by Country (2020-2025)
Table 23. Americas CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 24. Americas CellTherapy CDMO Market Size Market Share byType (2020-2025)
Table 25. Americas CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Table 27. APAC CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Table 29. APAC CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 30. APAC CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CellTherapy CDMO Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CellTherapy CDMO Market Size Market Share by Country (2020-2025)
Table 33. Europe CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 34. Europe CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CellTherapy CDMO Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CellTherapy CDMO Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa CellTherapy CDMO Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CellTherapy CDMO
Table 39. Key Market Challenges & Risks of CellTherapy CDMO
Table 40. Key IndustryTrends of CellTherapy CDMO
Table 41. Global CellTherapy CDMO Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global CellTherapy CDMO Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global CellTherapy CDMO Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global CellTherapy CDMO Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Charles River Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 46. Charles River CellTherapy CDMO Product Offered
Table 47. Charles River CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Charles River Main Business
Table 49. Charles River Latest Developments
Table 50.The Discovery Labs Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 51.The Discovery Labs CellTherapy CDMO Product Offered
Table 52.The Discovery Labs CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.The Discovery Labs Main Business
Table 54.The Discovery Labs Latest Developments
Table 55. BIOCENTRIQ Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 56. BIOCENTRIQ CellTherapy CDMO Product Offered
Table 57. BIOCENTRIQ CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. BIOCENTRIQ Main Business
Table 59. BIOCENTRIQ Latest Developments
Table 60.FUJIFILM Diosynth Biotechnologies Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 61.FUJIFILM Diosynth Biotechnologies CellTherapy CDMO Product Offered
Table 62.FUJIFILM Diosynth Biotechnologies CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.FUJIFILM Diosynth Biotechnologies Main Business
Table 64.FUJIFILM Diosynth Biotechnologies Latest Developments
Table 65. Exothera Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 66. Exothera CellTherapy CDMO Product Offered
Table 67. Exothera CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Exothera Main Business
Table 69. Exothera Latest Developments
Table 70. WuXi AppTec Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 71. WuXi AppTec CellTherapy CDMO Product Offered
Table 72. WuXi AppTec CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. WuXi AppTec Main Business
Table 74. WuXi AppTec Latest Developments
Table 75. Pharmaron Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 76. Pharmaron CellTherapy CDMO Product Offered
Table 77. Pharmaron CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pharmaron Main Business
Table 79. Pharmaron Latest Developments
Table 80. OBiO Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 81. OBiO CellTherapy CDMO Product Offered
Table 82. OBiO CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. OBiO Main Business
Table 84. OBiO Latest Developments
Table 85. CellTherapies Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 86. CellTherapies CellTherapy CDMO Product Offered
Table 87. CellTherapies CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. CellTherapies Main Business
Table 89. CellTherapies Latest Developments
Table 90. AGC Biologics Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 91. AGC Biologics CellTherapy CDMO Product Offered
Table 92. AGC Biologics CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AGC Biologics Main Business
Table 94. AGC Biologics Latest Developments
Table 95. Cytiva Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 96. Cytiva CellTherapy CDMO Product Offered
Table 97. Cytiva CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Cytiva Main Business
Table 99. Cytiva Latest Developments
Table 100. Helixmith Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 101. Helixmith CellTherapy CDMO Product Offered
Table 102. Helixmith CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Helixmith Main Business
Table 104. Helixmith Latest Developments
Table 105.ThermoGenesis Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 106.ThermoGenesis CellTherapy CDMO Product Offered
Table 107.ThermoGenesis CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108.ThermoGenesis Main Business
Table 109.ThermoGenesis Latest Developments
Table 110. Anemocyte Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 111. Anemocyte CellTherapy CDMO Product Offered
Table 112. Anemocyte CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Anemocyte Main Business
Table 114. Anemocyte Latest Developments
Table 115.ThermoFisher Scientific Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 116.ThermoFisher Scientific CellTherapy CDMO Product Offered
Table 117.ThermoFisher Scientific CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. CBM Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 121. CBM CellTherapy CDMO Product Offered
Table 122. CBM CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. CBM Main Business
Table 124. CBM Latest Developments
Table 125. Bio Elpida Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 126. Bio Elpida CellTherapy CDMO Product Offered
Table 127. Bio Elpida CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Bio Elpida Main Business
Table 129. Bio Elpida Latest Developments
Table 130. Genezen Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 131. Genezen CellTherapy CDMO Product Offered
Table 132. Genezen CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Genezen Main Business
Table 134. Genezen Latest Developments
Table 135. CCRM Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 136. CCRM CellTherapy CDMO Product Offered
Table 137. CCRM CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. CCRM Main Business
Table 139. CCRM Latest Developments
Table 140. RoslinCT Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 141. RoslinCT CellTherapy CDMO Product Offered
Table 142. RoslinCT CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. RoslinCT Main Business
Table 144. RoslinCT Latest Developments
Table 145. GenScript ProBio Details, CompanyType, CellTherapy CDMO Area Served and Its Competitors
Table 146. GenScript ProBio CellTherapy CDMO Product Offered
Table 147. GenScript ProBio CellTherapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. GenScript ProBio Main Business
Table 149. GenScript ProBio Latest Developments
LIST OFFIGURES
Figure 1. CellTherapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CellTherapy CDMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CellTherapy CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CellTherapy CDMO Sales Market Share by Country/Region (2024)
Figure 8. CellTherapy CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CellTherapy CDMO Market Size Market Share byType in 2024
Figure 10. CellTherapy CDMO in Commercial
Figure 11. Global CellTherapy CDMO Market: Commercial (2020-2025) & ($ millions)
Figure 12. CellTherapy CDMO in Academic Research
Figure 13. Global CellTherapy CDMO Market: Academic Research (2020-2025) & ($ millions)
Figure 14. CellTherapy CDMO in Others
Figure 15. Global CellTherapy CDMO Market: Others (2020-2025) & ($ millions)
Figure 16. Global CellTherapy CDMO Market Size Market Share by Application in 2024
Figure 17. Global CellTherapy CDMO Revenue Market Share by Player in 2024
Figure 18. Global CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 20. APAC CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 21. Europe CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa CellTherapy CDMO Market Size 2020-2025 ($ millions)
Figure 23. Americas CellTherapy CDMO Value Market Share by Country in 2024
Figure 24. United States CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC CellTherapy CDMO Market Size Market Share by Region in 2024
Figure 29. APAC CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 30. APAC CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 31. China CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe CellTherapy CDMO Market Size Market Share by Country in 2024
Figure 38. Europe CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 39. Europe CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 41.France CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa CellTherapy CDMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa CellTherapy CDMO Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa CellTherapy CDMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries CellTherapy CDMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 54. APAC CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 55. Europe CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 57. United States CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 58. Canada CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 61. China CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 62. Japan CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 63. Korea CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 65. India CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 66. Australia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 67. Germany CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 68.France CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 69. UK CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 70. Italy CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 71. Russia CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 74. Israel CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 75.Turkey CellTherapy CDMO Market Size 2026-2031 ($ millions)
Figure 76. Global CellTherapy CDMO Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global CellTherapy CDMO Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries CellTherapy CDMO Market Size 2026-2031 ($ millions)
More Publications
Global Industrial Machine Vision Light Source Market Growth 2025-2031
US$ 3,660.00
May 2025
116 pages
Global Public Safety LTE Device Market Growth 2025-2031
US$ 3,660.00
November 2026
118 pages
Global User and Entity Behavior Analytics Solutions Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
135 pages
Global Commercial LED Billboard Lights Market Growth 2025-2031
US$ 3,660.00
November 2025
145 pages
Global Public Transportation Dispatch Software Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
114 pages
